Mindfulness-Based Stress Reduction in Women with Overweight or Obesity: A Randomized Clinical Trial.

Nazia Raja-Khan, Katrina Agito, Julie Shah, Christy M Stetter, Theresa S Gustafson, Holly Socolow, Allen R Kunselman, Diane K Reibel, Richard S Legro
Author Information
  1. Nazia Raja-Khan: Division of Endocrinology, Diabetes, and Metabolism, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  2. Katrina Agito: Division of Endocrinology, Diabetes, and Metabolism, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  3. Julie Shah: Division of Endocrinology, Diabetes, and Metabolism, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  4. Christy M Stetter: Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  5. Theresa S Gustafson: Department of Clinical Nutrition, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  6. Holly Socolow: Division of Endocrinology, Diabetes, and Metabolism, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  7. Allen R Kunselman: Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  8. Diane K Reibel: Jefferson-Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  9. Richard S Legro: Department of Obstetrics and Gynecology, Penn State College of Medicine, Hershey, Pennsylvania, USA.

Abstract

OBJECTIVE: To evaluate the feasibility and cardiometabolic effects of mindfulness-based stress reduction (MBSR) in women with overweight or obesity.
METHODS: Eighty-six women with BMI ≥ 25 kg/m were randomized to 8 weeks of MBSR or health education and followed for 16 weeks. The primary outcome was the Toronto Mindfulness Scale. Secondary outcomes included the Perceived Stress Scale-10, fasting glucose, and blood pressure.
RESULTS: Compared to health education, the MBSR group demonstrated significantly improved mindfulness at 8 weeks (mean change from baseline, 4.5 vs. -1.0; P = 0.03) and significantly decreased perceived stress at 16 weeks (-3.6 vs. -1.3, P = 0.01). In the MBSR group, there were significant reductions in fasting glucose at 8 weeks (-8.9 mg/dL, P = 0.02) and at 16 weeks (-9.3 mg/dL, P = 0.02) compared to baseline. Fasting glucose did not significantly improve in the health education group. There were no significant changes in blood pressure, weight, or insulin resistance in the MBSR group.
CONCLUSIONS: In women with overweight or obesity, MBSR significantly reduces stress and may have beneficial effects on glucose. Future studies demonstrating long-term cardiometabolic benefits of MBSR will be key for establishing MBSR as an effective tool in the management of obesity.

Associated Data

ClinicalTrials.gov | NCT01464398

References

  1. Ann Behav Med. 2008 Jun;35(3):331-40 [PMID: 18535870]
  2. Sleep. 2010 Jun;33(6):781-92 [PMID: 20550019]
  3. Brain Behav Immun. 2003 Aug;17(4):276-85 [PMID: 12831830]
  4. Obes Rev. 2014 Jun;15(6):453-61 [PMID: 24636206]
  5. Obesity (Silver Spring). 2016 Apr;24(4):794-804 [PMID: 26955895]
  6. J Behav Med. 2012 Jun;35(3):272-85 [PMID: 21597980]
  7. JAMA Intern Med. 2014 Mar;174(3):357-68 [PMID: 24395196]
  8. Altern Ther Health Med. 2007 Sep-Oct;13(5):36-8 [PMID: 17900040]
  9. PLoS One. 2015 Jun 03;10(6):e0127447 [PMID: 26038824]
  10. Hypertension. 2005 Jan;45(1):142-61 [PMID: 15611362]
  11. Psychoneuroendocrinology. 2004 May;29(4):448-74 [PMID: 14749092]
  12. Complement Ther Med. 2013 Aug;21(4):430-9 [PMID: 23876574]
  13. Curr Obes Rep. 2015 Mar;4(1):141-6 [PMID: 26627097]
  14. Contemp Clin Trials. 2015 Mar;41:287-97 [PMID: 25662105]
  15. Gen Hosp Psychiatry. 2001 Jul-Aug;23(4):183-92 [PMID: 11543844]
  16. Diabetes Care. 2014 Sep;37(9):2427-34 [PMID: 24898301]
  17. Exp Clin Endocrinol Diabetes. 2014 Jun;122(6):341-9 [PMID: 24798861]
  18. Brain Behav Immun. 2003 Oct;17(5):350-64 [PMID: 12946657]
  19. J Clin Endocrinol Metab. 1998 Jun;83(6):1842-5 [PMID: 9626106]
  20. Curr Cardiol Rep. 2015 Dec;17 (12 ):112 [PMID: 26482755]
  21. JAMA. 2008 Sep 17;300(11):1350-2 [PMID: 18799450]
  22. Behav Sleep Med. 2011 Dec 28;10(1):6-24 [PMID: 22250775]
  23. J Clin Psychol. 2006 Dec;62(12):1445-67 [PMID: 17019673]
  24. JAMA. 2014 Feb 26;311(8):806-14 [PMID: 24570244]
  25. JAMA Intern Med. 2015 Apr;175(4):494-501 [PMID: 25686304]
  26. Psychoneuroendocrinology. 2012 Jul;37(7):917-28 [PMID: 22169588]
  27. Am J Physiol Endocrinol Metab. 2011 Jul;301(1):E1-E10 [PMID: 21487075]
  28. Eat Disord. 2011 Jan-Feb;19(1):49-61 [PMID: 21181579]
  29. J Consult Clin Psychol. 2007 Apr;75(2):336-43 [PMID: 17469891]
  30. J Clin Psychol. 2010 Jan;66(1):17-33 [PMID: 19998425]
  31. J Health Psychol. 2016 Sep;21(9):2108-21 [PMID: 25673371]
  32. Appl Nurs Res. 2014 Nov;27(4):227-30 [PMID: 24629718]
  33. Diabetes Care. 2013 Apr;36(4):823-30 [PMID: 23193218]
  34. J Pers Soc Psychol. 1988 Jun;54(6):1063-70 [PMID: 3397865]

Grants

  1. K23 AT006340/NCCIH NIH HHS
  2. UL1 TR000127/NCATS NIH HHS
  3. UL1 TR002014/NCATS NIH HHS

MeSH Term

Adult
Blood Glucose
Blood Pressure
Body Mass Index
Body Weight
Female
Follow-Up Studies
Humans
Insulin Resistance
Middle Aged
Mindfulness
Obesity
Obesity Management
Overweight
Stress, Psychological
Treatment Outcome
Waist Circumference

Chemicals

Blood Glucose

Word Cloud

Created with Highcharts 10.0.0MBSRweeksglucosegroupsignificantlyP = 0stresswomenobesity8healtheducation16cardiometaboliceffectsoverweightStressfastingbloodpressurebaselinevs-13significantmg/dL02OBJECTIVE:evaluatefeasibilitymindfulness-basedreductionMETHODS:Eighty-sixBMI ≥ 25kg/mrandomizedfollowedprimaryoutcomeTorontoMindfulnessScaleSecondaryoutcomesincludedPerceivedScale-10RESULTS:Compareddemonstratedimprovedmindfulnessmeanchange45003decreasedperceived-3601reductions-89-9comparedFastingimprovechangesweightinsulinresistanceCONCLUSIONS:reducesmaybeneficialFuturestudiesdemonstratinglong-termbenefitswillkeyestablishingeffectivetoolmanagementMindfulness-BasedReductionWomenOverweightObesity:RandomizedClinicalTrial

Similar Articles

Cited By